Skip to main content
Taylor & Francis Group Logo
Advanced Search

Click here to search books using title name,author name and keywords.

  • Login
  • Hi, User  
    • Your Account
    • Logout
Advanced Search

Click here to search books using title name,author name and keywords.

Breadcrumbs Section. Click here to navigate to respective pages.

Chapter

In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export

Chapter

In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export

DOI link for In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export

In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export book

In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export

DOI link for In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export

In Vivo Influence of Serum Amyloid A 2.1 and its Active Domains on Macrophage Cholesterol Export book

ByShui-Pang Tam, Robert Kisilevsky
BookAmyloid and Amyloidosis

Click here to navigate to parent product.

Edition 1st Edition
First Published 2004
Imprint CRC Press
Pages 3
eBook ISBN 9780429125249

ABSTRACT

The accumulation of lipids, especially cholesterol, in several vascular cell types such as macrophages and smooth muscle cells, is a defining pathologic feature of atherosclerosis. Serum amyloid A (SAA) isoforms 1.1 and 2.1 are acute phase proteins produced by the liver in response to any acute tissue injury. This chapter aims to characterize and define the effect of SAA2.1 on cholesterol efflux from cholesterol-laden macrophages in vivo. It demonstrates that the in vivo release of radiolabeled cholesterol from intravenously injected cholesterol-laden J774 macrophages is not a function of cell death nor of the destruction of these cells by an immune or ongoing inflammatory reaction but rather is dependent on a functional transporter. The cholesterol release was apparent within 6 h of the administration of isoform 2.1 or its relevant peptides, and peaked approximately16 h after the injection of these specific liposomes.

T&F logoTaylor & Francis Group logo
  • Policies
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
    • Cookie Policy
  • Journals
    • Taylor & Francis Online
    • CogentOA
    • Taylor & Francis Online
    • CogentOA
  • Corporate
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
    • Taylor & Francis Group
  • Help & Contact
    • Students/Researchers
    • Librarians/Institutions
    • Students/Researchers
    • Librarians/Institutions
  • Connect with us

Connect with us

Registered in England & Wales No. 3099067
5 Howick Place | London | SW1P 1WG © 2021 Informa UK Limited